Page last updated: 2024-09-03

tazobactam and Obesity

tazobactam has been researched along with Obesity in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's4 (66.67)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Jain, M; Mahmoud, A; Nicolau, DP; Nutley, K; Rhodes, NJ; Scheetz, MH; Shah, A; Sutherland, C1
Aubron, C; Corallo, C1
Cheatham, SC; Chung, EK; Fleming, MR; Healy, DP; Kays, MB; Shea, KM1
Batista, N; Fernández, MP; Gambra, ML; Rodríguez, L1
Jahagirdar, R; Khadilkar, AV; Khadilkar, VV; Lalwani, S; Rustagi, VT1
Beumier, M; Cotton, F; De Backer, D; Hites, M; Jacobs, F; Lorent, S; Roisin, S; Seyler, L; Surin, R; Taccone, FS; Vincent, JL; Wolff, F1

Reviews

1 review(s) available for tazobactam and Obesity

ArticleYear
Clinical pharmacokinetics of ceftolozane and tazobactam in an obese patient receiving continuous venovenous haemodiafiltration: A patient case and literature review.
    Journal of global antimicrobial resistance, 2020, Volume: 21

    Topics: Cephalosporins; Continuous Renal Replacement Therapy; Humans; Obesity; Tazobactam

2020

Trials

1 trial(s) available for tazobactam and Obesity

ArticleYear
Population pharmacokinetics and pharmacodynamics of piperacillin and tazobactam administered by prolonged infusion in obese and nonobese patients.
    Journal of clinical pharmacology, 2015, Volume: 55, Issue:8

    Topics: Adult; Aged; Anti-Bacterial Agents; Body Mass Index; Body Weight; Computer Simulation; Creatinine; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Models, Biological; Monte Carlo Method; Obesity; Penicillanic Acid; Piperacillin; Tazobactam

2015

Other Studies

4 other study(ies) available for tazobactam and Obesity

ArticleYear
β-Lactams Dosing in Overweight Critically Ill Patients: Are We Driving in the Dark?
    Critical care medicine, 2017, Volume: 45, Issue:5

    Topics: beta-Lactams; Critical Illness; Humans; Obesity; Overweight; Tazobactam

2017
[Fournier's gangrene caused by Streptococcus agalactiae in a non-pregnant woman].
    Enfermedades infecciosas y microbiologia clinica, 2009, Volume: 27, Issue:4

    Topics: Adult; Anti-Bacterial Agents; Clindamycin; Combined Modality Therapy; Debridement; Diabetes Mellitus, Type 1; Disease Susceptibility; Drug Therapy, Combination; Female; Fournier Gangrene; Humans; Metronidazole; Obesity; Penicillanic Acid; Perineum; Piperacillin; Reoperation; Streptococcal Infections; Streptococcus agalactiae; Tazobactam

2009
Right atrial thrombus in a six- year- old Indian boy with metabolic syndrome.
    Journal of pediatric endocrinology & metabolism : JPEM, 2010, Volume: 23, Issue:6

    Topics: Acanthosis Nigricans; Anti-Bacterial Agents; Anticoagulants; Child; Drug Therapy, Combination; Echocardiography, Doppler; Heart Atria; Heart Diseases; Heparin, Low-Molecular-Weight; Humans; Male; Metabolic Syndrome; Obesity; Penicillanic Acid; Piperacillin; Positive-Pressure Respiration; Tazobactam; Thrombosis; Treatment Outcome; Warfarin

2010
Case-control study of drug monitoring of β-lactams in obese critically ill patients.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Case-Control Studies; Cefepime; Ceftazidime; Cephalosporins; Drug Monitoring; Enzyme Inhibitors; Female; Humans; Male; Meropenem; Middle Aged; Obesity; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Renal Replacement Therapy; Sepsis; Shock, Septic; Tazobactam; Thienamycins; Young Adult

2013